Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 24, 2017 - Issue 1
235
Views
11
CrossRef citations to date
0
Altmetric
Original Article

CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects

, , , , , , , , , , & show all
Pages 42-51 | Received 11 Sep 2016, Accepted 15 Mar 2017, Published online: 10 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza. (2020) Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opinion on Emerging Drugs 25:3, pages 319-335.
Read now
Morie A. Gertz, Morton Scheinberg, Márcia Waddington-Cruz, Stephen B. Heitner, Chafic Karam, Brian Drachman, Sami Khella, Carol Whelan & Laura Obici. (2019) Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis. Expert Review of Clinical Pharmacology 12:8, pages 701-711.
Read now

Articles from other publishers (8)

Yutaka Takaoka, Aki Sugano, Yoshitomo Morinaga, Mika Ohta, Kenji Miura, Haruyuki Kataguchi, Minoru Kumaoka, Shigemi Kimura & Yoshimasa Maniwa. (2022) Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2. Microbial Risk Analysis 22, pages 100227.
Crossref
Monica Alcantara, Michelle M. Mezei, Steven K. Baker, Ari Breiner, Priya Dhawan, Amanda Fiander, Nowell M. Fine, Christopher Hahn, Hans D. Katzberg, Shahin Khayambashi, Rami Massie, Genevieve Matte, Brendan Putko, Zaeem Siddiqi, Diego Delgado & Vera Bril. (2021) Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 49:1, pages 7-18.
Crossref
Bin Zhong, Xianhua Huang, Yizhou Zheng, Xiaohua Guo & Longhuo Wu. (2021) The discovery and development of transthyretin amyloidogenesis inhibitors: what are the lessons?. Future Medicinal Chemistry 13:23, pages 2083-2105.
Crossref
Matthew Capustin & William H. Frishman. (2021) Transthyretin Cardiac Amyloidosis and Novel Therapies to Treat This Not-so-rare Cause of Cardiomyopathy. Cardiology in Review 29:5, pages 263-273.
Crossref
Christian Bailly & Gérard Vergoten. (2020) Flurbiprofen as a biphenyl scaffold for the design of small molecules binding to PD-L1 protein dimer. Biochemical Pharmacology 178, pages 114042.
Crossref
Valentina Loconte, Ilaria Menozzi, Alberto Ferrari, Claudia Folli, Bruno P. Imbimbo, Giuseppe Zanotti & Rodolfo Berni. (2019) Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin. Journal of Structural Biology 208:2, pages 165-173.
Crossref
Michael A. Hollas, Manel Ben Aissa, Sue H. Lee, Jesse M. Gordon-Blake & Gregory R.J. Thatcher. (2019) Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery. Nitric Oxide 82, pages 59-74.
Crossref
Mika Ohta, Aki Sugano, Naoya Hatano, Hirotaka Sato, Hirofumi Shimada, Hitoshi Niwa, Toshiyuki Sakaeda, Hajime Tei, Yoshiyuki Sakaki, Ken-ichi Yamamura & Yutaka Takaoka. (2017) Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis. Transgenic Research 27:1, pages 15-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.